Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
02/2003
02/06/2003WO2002002095A3 Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin
02/06/2003WO2002002093A3 Combination containing an antifolate and methylmalonic acid lowering agent
02/06/2003WO2001093897A9 Angiostatin and endostatin binding proteins and methods of use
02/06/2003WO2001066139A9 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cell
02/06/2003WO2001047946A3 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR
02/06/2003US20030028923 Nucleotide sequences coding enzymatic polypeptide for use in the generation of disease resistant plants
02/06/2003US20030028038 Semi-synthetic taxanes with antitumor and antiangiogenetic activities
02/06/2003US20030028028 1-oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels
02/06/2003US20030028018 Treating diseases characterized by activity of vascular endothelial growth factor receptor tyrosine kinases such as cancer
02/06/2003US20030028015 Especially bi- or tri- selophenes
02/06/2003US20030028008 Nucleotide sequences coding polypeptide for use in the treatment of urogenital, tumor, antherosclerotic and kidney disorders
02/06/2003US20030028006 Cytokine receptor common gamma chain like
02/06/2003US20030028004 68730 and 69112, protein kinase molecules and uses therefor
02/06/2003US20030028000 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferative disorders
02/06/2003US20030027999 143 human secreted proteins
02/06/2003US20030027855 Preparation of a derivative or analog of baccatin III or 10-desacetyl baccatin III having a C9 hydroxy substituent by selective reduction of the C9 keto compound
02/06/2003US20030027851 Readily soluble crystal modification; specific X-ray diffraction pattern obtained with a focusing Debye-Scherrer beam and Cu-K alpha 1-radiation
02/06/2003US20030027845 Ether derivatives useful as inhibitors of PDE4 isozymes
02/06/2003US20030027840 Estrogen receptor modulators
02/06/2003US20030027839 Farnesyl protein transferase inhiitors for treating breast cancer
02/06/2003US20030027830 Administering to a cancer patient an effective amount of chalcone or its derivaties to treat the tumor/cancer
02/06/2003US20030027820 Method for treating fibrotic diseases or other indications V
02/06/2003US20030027818 Treatment of cancers
02/06/2003US20030027808 Imidazoly-5-yl)methyl-2-quinolinone derivatives, together with platinum coordination compound selected from cisplatin or carboplatin; useful as anticarcinogenic agent
02/06/2003US20030027807 Vitronectin receptor antagonists, their preparation and their use
02/06/2003US20030027804 Administering to the mammal a menopause disorder effective amount of an orally deliverable pharmaceutically- acceptable sex hormone binding globulin synthesis inhibiting agent, and at least one of a non-orally deliverable steroids
02/06/2003US20030027800 LPA receptor agonists and antagonists and methods of use
02/06/2003US20030027799 As anticancer agents
02/06/2003US20030027794 N-heterocyclic derivatives as NOS inhibitors
02/06/2003US20030027783 Introducing into the cell an RNA comprising a double stranded structure having nucleotide sequence which is substantially identical to part of target gene and which is derived from an endogenous template; verifying inhibition of expression
02/06/2003US20030027776 For detecting, therapy, prophylaxis and/or prognosing disorders related to the tissues where these cancer antigens are expressed
02/06/2003US20030027768 For therapy of diseases and conditions mediated by undesired and uncontrolled cell invasion and/or angiogenesis
02/06/2003US20030027767 To cause apoptosis in colon cancer and prostate cancer cells
02/06/2003US20030027765 Therapeutic peptides having a motif that binds specifically to non-acetylated H3 and H4 histones for cancer therapy
02/06/2003US20030027302 Ligand for use in radioimmunotherapy
02/06/2003US20030027297 19 human secreted proteins
02/06/2003US20030027284 Tumor necrosis factor-gamma
02/06/2003US20030027261 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof
02/06/2003US20030027253 Nucleotides equences codin polypeptide for use in the treatment of cancer
02/06/2003US20030027248 Human cDNAs and proteins and uses thereof
02/06/2003US20030027246 Prostate protein for use in the diagnosis and treatment of cancer
02/06/2003US20030027230 Detection of antiproliferative agents for treatment of ovarian cancer; obtain cells, incubate with modulator, monitor cells for reduction in cancer activity, reduction in cancer activity indicates antiproliferative agents
02/06/2003US20030027211 Fetuin-MGP-mineral complex in serum
02/06/2003US20030027188 SLC7s as modifiers of the p53 pathway and methods of use
02/06/2003US20030027177 Human DNA mismatch repair proteins
02/06/2003US20030027161 Human cDNAs and proteins and uses thereof
02/06/2003US20030027158 Novel nucleic acid sequences encoding human breast tumor-associated protein 47-like polypeptides
02/06/2003US20030027130 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of viral diseases
02/06/2003US20030026862 (+)-Cycloolivil as antioxidant obtained from a new natural source namely stereospermum personatum
02/06/2003US20030026861 Anticancer agents; from soybeans
02/06/2003US20030026840 Immobilized into polyoxyethylene glycol
02/06/2003US20030026804 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
02/06/2003US20030026801 Methods for enhancing antibody-induced cell lysis and treating cancer
02/06/2003US20030026800 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
02/06/2003US20030026789 Anticancer agents
02/06/2003US20030026777 Detection and treatment of breast disease
02/06/2003US20030026764 Administering antibodies; anticancer agents
02/06/2003US20030024534 Removable stent and method of using the same
02/06/2003CA2857312A1 Nucleic acids, polypeptides, and methods for modulating apoptosis using deoxyhypusine synthase (dhs)
02/06/2003CA2493596A1 Novel targeted delivery system for bioactive agents
02/06/2003CA2455681A1 An inducer of apoptosis
02/06/2003CA2455602A1 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics
02/06/2003CA2454822A1 Nucleic acids, polypeptides, and methods for modulating apoptosis using apoptosis-specific eif-5a
02/06/2003CA2454805A1 Probiotic lactobacillus casei strains
02/06/2003CA2454803A1 Probiotic bifidobacterium strains
02/06/2003CA2454802A1 Novel class ii cytokine receptors and uses thereof
02/06/2003CA2454734A1 New isolated dendritic cells, a process for preparing the same and their use in pharmaceutical compositions
02/06/2003CA2454150A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same
02/06/2003CA2453894A1 Antisense modulation of hormone-sensitive lipase expression
02/06/2003CA2453880A1 Use of glycosylceramides as adjuvants for vaccines against infections and cancer
02/06/2003CA2453561A1 Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent
02/06/2003CA2452328A1 Substituted piperidines as modulators of the melanocortin receptor
02/06/2003CA2452259A1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors
02/06/2003CA2450073A1 Compositions and methods for modulating blood-brain barrier transport
02/05/2003WO2002014280A1 Piperidine derivatives and drugs containing these derivatives as the active ingredient
02/05/2003EP1281962A1 Method for the screening of compounds that inhibit the interaction between a proline-rich peptide and an SH3 domain comprising peptide
02/05/2003EP1281758A2 Four human zinc-finger-containing proteins : MDZ3, MDZ4, MDZ7 and MDZ12
02/05/2003EP1281756A1 Regulator of calcineurin
02/05/2003EP1281711A1 Interstrand crosslinking agents for dna and compounds therefor
02/05/2003EP1281709A1 Novel heterocyclic compounds with anti-inflammatory activity
02/05/2003EP1281403A1 Dietetic and/or pharmaceutical compositions containing a plant extract and probiotic microorganisms
02/05/2003EP1281397A1 Orally administered controlled drug delivery system providing temporal and spatial control
02/05/2003EP1280932A1 Interfering with telomere maintenance in treatment of diseases
02/05/2003EP1280924A2 Cloning of corynebacteriaceae histidine ammonia lyase and therapeutic uses
02/05/2003EP1280923A2 14094, a human trypsin family member and uses thereof
02/05/2003EP1280921A1 Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapy
02/05/2003EP1280918A2 Lipid metabolism enzymes
02/05/2003EP1280917A2 21657, a human short-chain dehydrogenase and uses thereof
02/05/2003EP1280908A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2
02/05/2003EP1280907A2 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
02/05/2003EP1280906A2 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
02/05/2003EP1280905A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene carboxy terminal peptides
02/05/2003EP1280903A2 Ph domain-interacting protein
02/05/2003EP1280900A2 Dendritic cell co-stimulatory molecules
02/05/2003EP1280891A1 Methods for identifying compounds useful for inhibiting geranylgeranyl diphosphate synthase
02/05/2003EP1280826A2 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
02/05/2003EP1280820A2 Anti-inflammatory compounds and uses thereof
02/05/2003EP1280816A1 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them
02/05/2003EP1280815A1 29 human secreted proteins
02/05/2003EP1280809A1 Antitumoral ecteinascidin derivatives
1 ... 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 ... 2211